Sofia Ajeganova

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Rheumatoid Arthritis

Body Composition

Interstitial Lung Disease

Top Venues

BMC rheumatology

Lupus science & medicine

Arthritis research & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Delphine Bertrand, Johan Joly, Barbara Neerinckx, Patrick Durez, Jan Lenaerts, Rik Joos, Kristof Thevissen, Tom Zwaenepoel, Johan Vanhoof, Silvana Di Romana, Veerle Taelman, Els Van Essche, Luk Corluy, Clio Ribbens, Marc Vanden Berghe, Mieke Devinck, Sofia Ajeganova, Anne Durnez, Yves Boutsen, Joëlle Margaux, Isabelle Peene, Jan Van Offel, Michaël Doumen, Sofia Pazmino, Elias De Meyst, Myroslava Kulyk, Nelly Creten, René Westhovens, Patrick Verschueren, null null
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial. RMD open 10 (3) (2024)
Björn Svensson, Maria L E Andersson, Inger Gjertsson, Ingiäld Hafström, Sofia Ajeganova, Kristina Forslind
Erosion-free rheumatoid arthritis: clinical and conceptional implications-a BARFOT study. BMC rheumatology 6 (1) (2022)
Björn Svensson, Maria L E Andersson, Inger Gjertsson, Ingiäld Hafström, Sofia Ajeganova, Kristina Forslind
Erosion-free rheumatoid arthritis: clinical and conceptional implications-a BARFOT study. BMC rheumatology 6 (1) (2022)
Björn Svensson, Maria L E Andersson, Inger Gjertsson, Ingiäld Hafström, Sofia Ajeganova, Kristina Forslind
Erosion-free rheumatoid arthritis: clinical and conceptional implications-a BARFOT study. BMC rheumatology 6 (1) (2022)
Sofia Ajeganova, Maria L E Andersson, Johan Frostegård, Ingiäld Hafström
Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events. Arthritis research & therapy 23 (1) (2021)
Sofia Ajeganova, Ingiäld Hafström, Johan Frostegård
Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years. Lupus science & medicine 8 (1) (2021)
Sofia Ajeganova, Margareta Wörnert, Ingiäld Hafström
Team Rehabilitation in Inflammatory Arthritis Benefits Functional Outcomes Along With Improved Body Composition Associated With Improved Cardiorespiratory Fitness. The Journal of rheumatology 48 (9) (2021)
Jitong Sun, Pritam Kumar Panda, Shailesh Kumar Samal, Rajeev Ahuja, Sofia Ajeganova, Ingiäld Hafström, Anquan Liu, Johan Frostegård
Effects of Atorvastatin on T-Cell Activation and Apoptosis in Systemic Lupus Erythematosus and Novel Simulated Interactions With C-Reactive Protein and Interleukin 6. ACR open rheumatology 3 (9) (2021)
Sofia Ajeganova, Ann De Becker, Rik Schots
Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still's disease: when dosage matters in overcoming secondary therapy resistance. Therapeutic advances in musculoskeletal disease 12 (2020)
Sofia Ajeganova, Thomas Gustafsson, Linnea Lindberg, Ingiäld Hafström, Johan Frostegård
Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients. Lupus science & medicine 7 (1) (2020)
Sofia Ajeganova, Daniel Tesfa, Hans Hägglund, Bengt Fadeel, Inger Vedin, Anna Linda Zignego, Jan Palmblad
Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab. Arthritis research & therapy 19 (1) (2017)